Method for the inhibition of restenosis associated with coronary intervention
US5385935A · kind A · utility
41Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 1993 |
| Grant date | Jan 31, 1995 |
| Priority date | — |
| Expiry date | Sep 7, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method for treating patients to inhibit restenosis associated with coronary intervention. A 600 mg dosage of Tranilast for a treatment period of three consecutive months after coronary intervention lowers the incidence of restenosis, and reduces the degree of stenosis in patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.